Oral Session 2-12A ALL: Clinical (1)

[OS2-12A-1] The optimal treatment strategy for Ph-negative ALL in CR1 in the era of high-intensity chemotherapy

Shinichi Kako¹, Fumihiko Hayakawa², Kiyotoshi Imai³, Junji Tanaka⁴, Shuichi Mizuta⁵, Satoshi Nishiwaki⁶, Heiwa Kanamori⁷, Kazuteru Ohashi⁸, Naoyuki Uchida⁹, Kazuhiro Ikegame¹⁰, Takahiro Fukuda¹¹, Tatsuo Ichinohe¹², Shuichi Ota¹³, Yoshinori Tanaka¹⁴, Tohru Murayama¹⁵, Shingo Kurahashi¹⁶, Toru Sakura¹⁷, Noriko Usui¹⁸, Shigeki Ohtake¹⁹, Hitoshi Kiyoi²⁰, Itaru Matsumura²¹, Yasushi Miyazaki²², Yoshiko Atsuta^23,24 (1.Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan, 2.Pathophysiological Laboratory Sciences, Nagoya University, Nagoya, Japan, 3.Miyanomori Hospital, Sapporo, Japan, 4.Hematology, Tokyo Women's Medical University, Tokyo, Japan, 5.Hematology and Immunology, Medicine, Kanazawa Medical University, Ishikawa, Japan, 6.Advanced Medicine, Nagoya University Hospital, Nagoya, Japan, 7.Hematology, Kanagawa Cancer Center, Yokohama, Japan, 8.Hematology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 9.Hematology, Toranomon Hospital, Tokyo, Japan, 10.Hematology, Hyogo College of Medicine, Hyogo, Japan, 11.Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan, 12.Hematol. Oncol., Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, 13.Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan, 14.Third Department of Internal Medicine, Yamaguchi University, Yamaguchi, Japan, 15.Hematology, Hyogo Cancer Center, Hyogo, Japan, 16.Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan, 17.Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan, 18.Clinical Oncology and Hematology, the Jikei University, Tokyo, Japan, 19.Kanazawa University, Kanazawa, Japan, 20.Hematology and Oncology, Nagoya University, Nagoya, Japan, 21.Hematology, Internal Medicine, Kindai University, Osaka, Japan, 22.Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan, 23.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 24.Healthcare Administration, Nagoya University, Nagoya, Japan)